ASCLETIS PHARMA INC (ASCLF:OTCMKTS)

$1.3 0.02 (1.5625%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 71

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ASCLETIS PHARMA INC (ASCLF:OTCMKTS) News Sources

Sagimet Announces Positive 52-Week Data from License Partner Ascletis’ Open-Label Phase 3 Clinical Trial Evaluating the Long-Term Safety of ASC40 (Denifanstat) Tablets in Patients with Moderate to Severe Acne

02-02-2026

yahoo.com

Sagimet Biosciences Showcases FASN Strategy, MASH Phase II Timeline and Acne Data at Guggenheim Conference

15-02-2026

marketbeat.com

Ascletis Pharma’s ASC36 Obesity Move Meets Strong Share Price Momentum

19-02-2026

yahoo.com

Ascletis Announces Initiation of Two Phase I Studies in U.S. for the Treatment of Obesity: ASC36 Once-Monthly Injection, an Amylin Receptor Peptide Agonist, and ASC36_35FDC Once-Monthly Injection, a Co-Formulation of ASC36 and GLP-1R/GIPR Peptide Agonist ASC35

10-08-2026

yahoo.com

Sagimet Biosciences Eyes U.S. Phase III Acne Study After Positive China Data

17-08-2026

marketbeat.com

Ascletis Announces First Participant Dosed in a Global Phase III Clinical Program of Once-Daily Oral Small Molecule GLP-1 Receptor Agonist ASC30 for Chronic Weight Management

30-08-2026

yahoo.com

Ascletis Announces Inclusion in the Hong Kong Stock Connect List under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs

07-09-2026

yahoo.com

Ascletis Announces Initiation of Phase I Study in U.S. for Oral Amylin Receptor Peptide Agonist ASC36 for the Treatment of Obesity

08-09-2026

yahoo.com

ASCLETIS PHARMA INC (ASCLF:OTCMKTS) Sentiment Trend

0 25 50 75 100 85 72 90 55 74 74 52 63 02-02-2026 15-02-2026 19-02-2026 10-08-2026 17-08-2026 30-08-2026 07-09-2026 08-09-2026 #1 #2 #3 #4 #5 #6 #7 #8 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ASCLETIS PHARMA INC (ASCLF:OTCMKTS) FAQs

toggle

What is the current price of ASCLETIS PHARMA INC (ASCLF:OTCMKTS)?

The current price of ASCLETIS PHARMA INC (ASCLF:OTCMKTS) is $1.3.


toggle

ASCLETIS PHARMA INC (ASCLF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of ASCLETIS PHARMA INC (ASCLF:OTCMKTS) since the previous trading day is $0.02.


toggle

ASCLETIS PHARMA INC (ASCLF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of ASCLETIS PHARMA INC (ASCLF:OTCMKTS) since the previous trading day is 1.5625%.


toggle

What is the most recent average sentiment score for ASCLETIS PHARMA INC (ASCLF:OTCMKTS)?

The most recent average sentiment score for ASCLETIS PHARMA INC (ASCLF:OTCMKTS) is 71 out of 100.


toggle

What is the most recent average sentiment for ASCLETIS PHARMA INC (ASCLF:OTCMKTS)?

The most recent sentiment for ASCLETIS PHARMA INC (ASCLF:OTCMKTS) is .


SEC-8K** Filing Available For ASCLETIS PHARMA INC (ASCLF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.